A trio of stock analysts this week examined the likely impacts on biopharma from Donald Trump’s election victory and ...
The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.
Researchers say new research findings might point to a major opportunity to act sooner to prevent rheumatoid arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback